Dystrophic skeletal muscle fibers display alterations at the level of calcium microdomains.
The spatiotemporal properties of the Ca(2+)-release process in skeletal muscle fibers from normal and mdx fibers were determined using the confocal-spot detection technique. The Ca(2+) indicator OGB-5N was used to record action potential-evoked fluorescence signals at consecutive locations separated by 200 nm along multiple sarcomeres of FDB fibers loaded with 10- and 30-mM EGTA. Three-dimensional reconstructions of fluorescence transients demonstrated the existence of microdomains of increased fluorescence around the Ca(2+)-release sites in both mouse strains. The Ca(2+) microdomains in mdx fibers were regularly spaced along the fiber axis, displaying a distribution similar to that seen in normal fibers. Nevertheless, both preparations differed in that in 10-mM EGTA Ca(2+) microdomains had smaller amplitudes and were wider in mdx fibers than in controls. In addition, Ca(2+)-dependent fluorescence transients recorded at selected locations within the sarcomere of mdx muscle fibers were not only smaller, but also slower than their counterparts in normal fibers. Notably, differences in the spatial features of the Ca(2+) microdomains recorded in mdx and normal fibers, but not in the amplitude and kinetics of the Ca(2+) transients, were eliminated in 30-mM EGTA. Our results consistently demonstrate that Ca(2+)-release flux calculated from release sites in mdx fibers is uniformly impaired with respect to those normal fibers. The Ca(2+)-release reduction is consistent with that previously measured using global detection techniques.
DiFranco
Marino
M
Department of Physiology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Woods
Christopher E
CE
Capote
Joana
J
Vergara
Julio L
JL
D000200:Action Potentials; D000818:Animals; D002118:Calcium / Q000378:metabolism*; D002614:Chelating Agents / Q000494:pharmacology; D004533:Egtazic Acid / Q000494:pharmacology; D007202:Indicators and Reagents / Q000032:analysis; D051379:Mice; D008810:Mice, Inbred C57BL; D018101:Mice, Inbred mdx; D018613:Microscopy, Confocal; D018485:Muscle Fibers, Skeletal / Q000187:drug effects / Q000378:metabolism*; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism*; D020388:Muscular Dystrophy, Duchenne / Q000503:physiopathology*; D012518:Sarcomeres / Q000378:metabolism
D002614:Chelating Agents; D007202:Indicators and Reagents; D004533:Egtazic Acid; D002118:Calcium
Biophys J. 2003 Aug;85(2):1080-97
12885654
J Gen Physiol. 2006 Jun;127(6):623-37
16735751
Cell. 1991 Sep 20;66(6):1121-31
1913804
J Physiol. 2005 Nov 1;568(Pt 3):867-80
16123111
Biochem Biophys Res Commun. 2006 Feb 17;340(3):865-71
16403451
J Gen Physiol. 2007 Sep;130(3):283-302
17724162
Cell. 1987 Dec 24;51(6):919-28
3319190
FEBS Lett. 1993 Jul 12;326(1-3):272-4
8325378
J Physiol. 1993 Jan;460:51-67
8487206
J Gen Physiol. 1995 Aug;106(2):259-336
8537818
J Neurol Sci. 1990 Jul;97(2-3):261-72
2119423
J Muscle Res Cell Motil. 1999 Oct;20(7):605-25
10672510
J Physiol. 2001 Sep 1;535(Pt 2):591-600
11533147
J Appl Physiol (1985). 2002 Feb;92(2):435-45
11796649
Lancet. 2002 Feb 23;359(9307):687-95
11879882
Biochim Biophys Acta. 1996 May 21;1290(1):4-8
8645705
Pflugers Arch. 2002 Feb;443(4):508-19
11907817
Biophys J. 1984 May;45(5):993-9
6329349
J Appl Physiol (1985). 2002 Aug;93(2):407-17
12133845
J Physiol. 2004 May 15;557(Pt 1):59-75
15004213
Muscle Nerve. 1985 Sep;8(7):576-9
4047089
J Histochem Cytochem. 2001 Apr;49(4):529-38
11259456
Neuron. 1998 Mar;20(3):389-99
9539117
Muscle Nerve. 1995 Oct;18(10):1147-54
7659109
Biophys J. 1993 Jun;64(6):1934-60
8369415
Nature. 1994 Feb 24;367(6465):739-41
8107869
Curr Opin Genet Dev. 2002 Jun;12(3):349-61
12076680
J Physiol. 2005 Jan 15;562(Pt 2):347-65
15528246
J Membr Biol. 2005 Nov;208(2):141-53
16645743